share_log

港股中国生物制药跌超7%

Hong Kong stock Sino Biopharmaceutical fell by more than 7%

Breakings ·  Aug 12, 2022 09:41
Sino Biopharmaceutical, a Hong Kong stock, fell more than 7 per cent, with Sino Biopharmaceutical announcing that its first-half net profit fell 78 per cent from a year earlier to 1.871 billion yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment